SCHEMBL31479368

SCHEMBL31479368

CCN(C(=O)c1cc(F)ccc1-c1cc(N2CCNCC2)cn2c(C)nc(Cl)c12)C(C)C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 6/20 0.34
HCRTR2 O43614 6/20 0.34
ACVR1 Q04771 3/20 0.34
BMPR1B O00238 2/20 0.34
KDR P35968 2/20 0.34
ACVR1B P36896 2/20 0.34
TGFBR1 P36897 2/20 0.34
ACVRL1 P37023 2/20 0.34
TGFBR2 P37173 2/20 0.34
PDGFRB P09619 1/20 0.34
HTR2C P28335 2/20 0.33
IDO1 P14902 1/20 0.33
TDO2 P48775 1/20 0.33
IDO2 Q6ZQW0 1/20 0.33
MAPKAPK2 P49137 2/20 0.32
MAP2 P11137 1/20 0.32
OPRM1 P35372 1/20 0.31
OPRD1 P41143 1/20 0.31
HDAC3 O15379 2/20 0.31
MAP4K4 O95819 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31479366 0.87 ENPP2 (0.39) IDO1TDO2IDO2
SCHEMBL31479226 0.85 HCRTR1 (0.35) HCRTR1HCRTR2
SCHEMBL31479296 0.85 HCRTR1 (0.36) HCRTR1HCRTR2ACVR1BMPR1BKDR
SCHEMBL31479463 0.84 MEN1 (0.39) HCRTR1HCRTR2
SCHEMBL31479662 0.83 HCRTR1 (0.35) HCRTR1HCRTR2ACVR1BMPR1BKDR
SCHEMBL31479725 0.81 HCRTR1 (0.36) HCRTR1HCRTR2ACVR1BMPR1BKDR
SCHEMBL31478997 0.79 HCRTR1 (0.36) HCRTR1HCRTR2ACVR1BMPR1BKDR
SCHEMBL31479007 0.78 GPBAR1 (0.37) HCRTR1HCRTR2
SCHEMBL31479549 0.77 HCRTR1 (0.35) HCRTR1HCRTR2
SCHEMBL31478968 0.77 HCRTR1 (0.36) HCRTR1HCRTR2HTR2COPRM1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025067111-A1 MENIN-MLL INTERACTION INHIBITOR AND PREPARATION METHOD THEREFOR, AND APPLICATION 苏州必扬医药科技有限公司 2025-04-03 WO disclosed